Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 7
2003 2
2004 3
2005 1
2006 4
2007 4
2008 7
2009 7
2010 9
2011 7
2012 7
2013 5
2014 1
2015 4
2016 6
2017 2
2018 3
2019 6
2020 3
2021 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
High-content screening. Introduction.
Trask OJ Jr, Davies A, Haney S. Trask OJ Jr, et al. Among authors: davies a. J Biomol Screen. 2010 Aug;15(7):719. doi: 10.1177/1087057110377885. J Biomol Screen. 2010. PMID: 20729342 No abstract available.
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
Collins DM, Madden SF, Gaynor N, AlSultan D, Le Gal M, Eustace AJ, Gately KA, Hughes C, Davies AM, Mahgoub T, Ballot J, Toomey S, O'Connor DP, Gallagher WM, Holmes FA, Espina V, Liotta L, Hennessy BT, O'Byrne KJ, Hasmann M, Bossenmaier B, O'Donovan N, Crown J. Collins DM, et al. Among authors: davies am. Clin Cancer Res. 2021 Feb 1;27(3):807-818. doi: 10.1158/1078-0432.CCR-20-2007. Epub 2020 Oct 29. Clin Cancer Res. 2021. PMID: 33122343 Free PMC article. Clinical Trial.
Drug Discovery Approaches Utilizing Three-Dimensional Cell Culture.
Ryan SL, Baird AM, Vaz G, Urquhart AJ, Senge M, Richard DJ, O'Byrne KJ, Davies AM. Ryan SL, et al. Among authors: davies am. Assay Drug Dev Technol. 2016 Jan-Feb;14(1):19-28. doi: 10.1089/adt.2015.670. Epub 2016 Jan 27. Assay Drug Dev Technol. 2016. PMID: 26866750 Review.
Screening out irrelevant cell-based models of disease.
Horvath P, Aulner N, Bickle M, Davies AM, Nery ED, Ebner D, Montoya MC, Östling P, Pietiäinen V, Price LS, Shorte SL, Turcatti G, von Schantz C, Carragher NO. Horvath P, et al. Among authors: davies am. Nat Rev Drug Discov. 2016 Nov;15(11):751-769. doi: 10.1038/nrd.2016.175. Epub 2016 Sep 12. Nat Rev Drug Discov. 2016. PMID: 27616293 Review.
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC.
Ryan SL, Beard S, Barr MP, Umezawa K, Heavey S, Godwin P, Gray SG, Cormican D, Finn SP, Gately KA, Davies AM, Thompson EW, Richard DJ, O'Byrne KJ, Adams MN, Baird AM. Ryan SL, et al. Among authors: davies am. Lung Cancer. 2019 Sep;135:217-227. doi: 10.1016/j.lungcan.2019.07.006. Epub 2019 Jul 12. Lung Cancer. 2019. PMID: 31446998
Hysterectomy: surgical route and complications.
Davies A, Hart R, Magos A, Hadad E, Morris R. Davies A, et al. Eur J Obstet Gynecol Reprod Biol. 2002 Sep 10;104(2):148-51. doi: 10.1016/s0301-2115(02)00068-4. Eur J Obstet Gynecol Reprod Biol. 2002. PMID: 12206928
91 results